The virtual reality training sessions were designed to feature "the same sights, sound and sensations a surgeon would encounter during real procedures." 

Michael J. Reardon, MD, professor of cardiothoracic surgery and Allison Family Distinguished chair of cardiovascular research at Houston Methodist DeBakey Heart and Vascular Center, presented pooled data at ACC.22 from the CoreValve SURTAVI trials that found transcatheter aortic valve replacement (TAVR) was more durable than surgical aortic valve replacement (SAVR) devices.

Sean Pokorney, MD, director of the arrhythmia core lab, Duke Clinical Research Institute, assistant professor of Medicine, Duke University, discusses a late-breaking ACC 2022 study that shows mortality is higher in patients with implantable electrophysiology (EP) device infections where the leads are not explanted.

Santiago Garcia, MD, lead author of the study and director of the structural heart program at The Christ Hospital in Cincinnati, Ohio, presented new data from the North American COVID-19 STEMI (NACMI) registry at ACC.22. Severity of heart attacks were reduced in vaccinated patients, with zero deaths in vaccinated patients in 2021.

Mass General cardiologist and Harvard professor Ami Bhatt, MD, predicts upcoming paradigm shifts in cardiology over the next decade. 

In a new video, Evans Pap­pas, MD, and Sujith Kalathiveetil, MD, both of Duly Health and Care in suburban Chicago, explain the shift toward office-based cardiac CT evaluations and the role of FFR-CT. 

Cardiothoracic surgeon Igor Mokryk, MD, spent last week taking his family to the Polish border. This week, he treated his first gunshot wound patient at the Heart Institute in Kyiv.

University Hospitals Health System tested the pricing change in a bid to boost outcomes in its service area.